Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
VEGF signaling pathway | R-HSA-194138 | map04370 | CP-863187 | 1981 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | CP-863187 | 1981 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | nifurtimox | 14987 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nifurtimox | 14987 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | nifurtimox | 14987 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | nifurtimox | 14987 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | nifurtimox | 14987 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | nifurtimox | 14987 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | anabasine | 1678 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | anabasine | 1678 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | anabasine | 1678 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | anabasine | 1678 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | anabasine | 1678 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | anabasine | 1678 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | antazoline | 2200 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | antazoline | 2200 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | antazoline | 2200 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | antazoline | 2200 | drug-path |
Asthma | R-HSA-444620 | map05310 | antazoline | 2200 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | antazoline | 2200 | drug-path |